Exchange: NASDAQ·Updated 11:56 AM EDT
TVRD logo

TVRD Tvardi Therapeutics, Inc.

$0.9947
$0.0353
(3.43%)
Today
EarningsNov 12
Mkt Cap$13.74M
Vol78,937.00

About TVRD

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
48

Neutral Sentiment

How do you feel about TVRD?

PLATINUM_TRADES
$TVRD Very nice so far I sold a little early but some members still in collecting more.. $1.43 Is major resistance on this one 🕜
1
CandleSnipe
$TVRD Travere reported $489M cash and cash equivalents and marketable securities at June 30, 2026...
1
PLATINUM_TRADES
$TVRD I took the tiny profits I can't take a risk in this market.. Will revisit... But I'm gonna stay green no matter how little 🤏

Advertisement|Remove ads.